Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Harmon

Showing results (111-120 of 147) with videos related to

Pageof 15
Sort By:
Emerging Infectious Diseases|August 24, 2019
Bourbon Virus in Wild and Domestic Animals, Missouri, USA, 2012-2013Katelin C Jackson, Thomas Gidlewski, J Jeffrey Root, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1992
Obliterative bronchiolitis after lung transplantation: a fibroproliferative disorder associated with platelet-derived growth factorM I Hertz, C A Henke, R E Nakhleh, et al.
Virus Research|May 16, 2024
Evaluation of two inoculation routes of an adenovirus-mediated viral protein inhibitor in a Crimean-Congo hemorrhagic fever mouse modelFlorine E M Scholte, Jessica R Spengler, Stephen R Welch, et al.
Antiviral Research|April 26, 2026
Distinct respiratory and neurological disease phenotypes in lethal Nipah virus Malaysia versus Bangladesh infection in IFNAR knockout miceTeresa E Sorvillo, Katherine A Davies, Stephen R Welch, et al.
Microorganisms|May 28, 2020
The Crimean-Congo Hemorrhagic Fever Virus NSm Protein is Dispensable for Growth In Vitro and Disease in Ifnar<sup>-/-</sup> MiceStephen R Welch, Florine E M Scholte, Jessica R Spengler, et al.
Antiviral Research|May 27, 2021
Viral replicon particles protect IFNAR<sup>-/</sup><sup>-</sup> mice against lethal Crimean-Congo hemorrhagic fever virus challenge three days after vaccinationJessica R Spengler, Stephen R Welch, Florine E M Scholte, et al.
The Journal of Infectious Diseases|November 21, 2019
Alterations in Blood Chemistry Levels Associated With Nipah Virus Disease in the Syrian Hamster ModelSarah C Genzer, Stephen R Welch, Florine E M Scholte, et al.
Environmental Toxicology and Chemistry|May 21, 2013
Comparing the effects of nanosilver size and coating variations on bioavailability, internalization, and elimination, using Lumbriculus variegatusJessica G Coleman, Alan J Kennedy, Anthony J Bednar, et al.
The Journal of Infectious Diseases|June 2, 2019
Protection From Lethal Lassa Disease Can Be Achieved Both Before and After Virus Exposure by Administration of Single-Cycle Replicating Lassa Virus Replicon ParticlesMarkus H Kainulainen, Jessica R Spengler, Stephen R Welch, et al.
Mbio|March 17, 2022
Defective Interfering Viral Particle Treatment Reduces Clinical Signs and Protects Hamsters from Lethal Nipah Virus DiseaseStephen R Welch, Jessica R Spengler, Jessica R Harmon, et al.
Pageof 15

Showing results (111-120 of 147) with videos related to

Sort By:
Pageof 15
Emerging Infectious Diseases|August 24, 2019
Bourbon Virus in Wild and Domestic Animals, Missouri, USA, 2012-2013Katelin C Jackson, Thomas Gidlewski, J Jeffrey Root, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1992
Obliterative bronchiolitis after lung transplantation: a fibroproliferative disorder associated with platelet-derived growth factorM I Hertz, C A Henke, R E Nakhleh, et al.
Virus Research|May 16, 2024
Evaluation of two inoculation routes of an adenovirus-mediated viral protein inhibitor in a Crimean-Congo hemorrhagic fever mouse modelFlorine E M Scholte, Jessica R Spengler, Stephen R Welch, et al.
Antiviral Research|April 26, 2026
Distinct respiratory and neurological disease phenotypes in lethal Nipah virus Malaysia versus Bangladesh infection in IFNAR knockout miceTeresa E Sorvillo, Katherine A Davies, Stephen R Welch, et al.
Microorganisms|May 28, 2020
The Crimean-Congo Hemorrhagic Fever Virus NSm Protein is Dispensable for Growth In Vitro and Disease in Ifnar<sup>-/-</sup> MiceStephen R Welch, Florine E M Scholte, Jessica R Spengler, et al.
Antiviral Research|May 27, 2021
Viral replicon particles protect IFNAR<sup>-/</sup><sup>-</sup> mice against lethal Crimean-Congo hemorrhagic fever virus challenge three days after vaccinationJessica R Spengler, Stephen R Welch, Florine E M Scholte, et al.
The Journal of Infectious Diseases|November 21, 2019
Alterations in Blood Chemistry Levels Associated With Nipah Virus Disease in the Syrian Hamster ModelSarah C Genzer, Stephen R Welch, Florine E M Scholte, et al.
Environmental Toxicology and Chemistry|May 21, 2013
Comparing the effects of nanosilver size and coating variations on bioavailability, internalization, and elimination, using Lumbriculus variegatusJessica G Coleman, Alan J Kennedy, Anthony J Bednar, et al.
The Journal of Infectious Diseases|June 2, 2019
Protection From Lethal Lassa Disease Can Be Achieved Both Before and After Virus Exposure by Administration of Single-Cycle Replicating Lassa Virus Replicon ParticlesMarkus H Kainulainen, Jessica R Spengler, Stephen R Welch, et al.
Mbio|March 17, 2022
Defective Interfering Viral Particle Treatment Reduces Clinical Signs and Protects Hamsters from Lethal Nipah Virus DiseaseStephen R Welch, Jessica R Spengler, Jessica R Harmon, et al.
Pageof 15